Why the study?
Does adriamycin induce cardiotoxicity via superoxide anion radical formation in animal models?
Does adriamycin induce cardiotoxicity via superoxide anion radical formation in animal models?
Adriamycin cardiotoxicity appears to be mediated by direct stimulation of superoxide anion radical formation in heart mitochondria, overwhelming local antioxidant defenses.
Answers are grounded in this paper and cite their sources.
Supports superoxide as adriamycin cardiotoxicity mechanism in animals; leaves open human relevance and therapeutic implications.
The investigation was undertaken to study a possible mechanism for adriamycin cardiotoxicity. The activities of superoxide dismutase and catalase in the heart of mice were increased significantly by the intraperitoneal administration of 15 mg/kg of adriamycin. In contrast, these enzymes in the liver and kidney were unaffected by this dose of adriamycin. In vitro studies revealed that adriamycin inhibited the NADH-cytochrome c oxidoreductase activity of mitochondria in the guinea pigs heart. Moreover adriamycin stimulated the formation of superoxide anion radical in mitochondria isolated from guinea pigs. Particularly, the formation of superoxide anion radical in the heart mitochondria was 5 times higher than that in the liver mitochondria particle. On the other hand, the contents of superoxide dismutase in the heart were significantly lower than that in the liver. These results suggest that the cardiotoxic effect of adriamycin is caused by the following mechanism: adriamycin directly stimulates the formation of superoxide anion radical, particularly in the heart mitochondria. In spite of the induction of defence enzymes such as superoxide dismutase and catalase, their abilities seem to be swamped by enhanced active oxygen radicals.
No takes yet. Share an insight, caveat, or question.
Adachi et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: